Brief: Control Bionics To Undertake Pro Rata Non- Renounceable Rights Issue
17/05/2023 02:36
May 17 (Reuters) - Control Bionics Ltd CBL.AX :
* WILL BE UNDERTAKING A PRO RATA NON- RENOUNCEABLE RIGHTS
ISSUE OF
ORDINARY FULLY PAID SHARES TO ELIGIBLE SHAREHOLDERS
* RIGHTS ISSUE AT ISSUE PRICE OF 9.5 AU CENTS PER SHARE TO
RAISE
UP TO ABOUT A$2.865 MILLION
Source text for Eikon: ID:nASX2prG9B
Further company coverage: CBL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device